XML 51 R35.htm IDEA: XBRL DOCUMENT v3.22.1
Stock Incentive Plan (Tables)
12 Months Ended
Jan. 29, 2022
Share-based Payment Arrangement [Abstract]  
Schedule of Estimated Fair Value of Options as of Grant Date by Using Black-Scholes Option Pricing Model
The fair value of options is estimated as of the date of grant using the Black-Scholes option pricing model with the following weighted average assumptions:
  Fiscal Year Ended
  January 29,
2022
January 30,
2021
February 1,
2020
Risk-free interest rate0.84 %0.28 %1.65 %
Dividend yield(a)
1.5 %1.4 %1.6 %
Expected volatility factor23.8 %26.5 %23.4 %
Expected option life5.0 years5.0 years4.9 years
Weighted average fair value of options issued$12.85 $11.29 $10.84 
(a)The reduction in the yield in fiscal 2021 reflected the temporary suspension of dividends due to the COVID-19 pandemic. TJX calculated an implied dividend yield of 1.4% by anticipating dividends to resume. The decrease in expected dividend yield reflected the suspension of dividend payments during the first nine months of fiscal 2021.
Schedule of Stock Options and Related Weighted Average Exercise Prices A summary of the status of TJX’s stock options and related weighted average exercise prices (“WAEP”) is presented below:
  Fiscal Year Ended
Shares in thousandsJanuary 29,
2022
January 30,
2021
February 1,
2020
  OptionsWAEPOptionsWAEPOptionsWAEP
Outstanding at beginning of year42,604 $41.79 45,065 $36.81 49,053 $32.02 
Granted5,324 70.48 6,268 57.32 6,150 56.74 
Exercised(7,160)32.04 (8,239)25.68 (9,518)24.40 
Forfeitures(535)57.55 (490)52.96 (620)46.37 
Outstanding at end of year40,233 $47.11 42,604 $41.79 45,065 $36.81 
Options exercisable at end of year29,159 $40.93 30,659 $36.05 32,276 $31.04 
Schedule of Stock Options Outstanding Expected to Vest and Stock Options Outstanding Exercisable
The following table summarizes information about stock options outstanding that were expected to vest and stock options outstanding that were exercisable as of January 29, 2022:
Shares
(in thousands)
Aggregate
Intrinsic
Value
(in thousands)
Weighted
Average
Remaining
Contract Life
WAEP
Options outstanding expected to vest(a)
10,281 $83,586 8.9 years$63.25 
Options exercisable29,159 $887,932 5.0 years$40.93 
Total outstanding options vested and expected to vest39,440 $971,518 6.0 years$46.75 
(a)Reflects 11 million unvested options, net of anticipated forfeitures.
Summary of Nonvested Performance-Based Stock Awards A summary of the status of the Company’s non-vested stock awards and changes during fiscal 2022 is presented below:
In thousands except grant date fair valueRestricted Stock UnitsPerformance Share UnitsTotal Stock AwardsWeighted
Average
Grant Date
Fair Value
Nonvested at beginning of year1,799 1,122 2,921 $51.36 
Granted513 307 820 65.53 
Vested(460)(378)(838)52.77 
Forfeited(16)(4)(20)60.24 
Modification— (115)(115)54.99 
Nonvested at end of year1,836 932 2,768 58.91